lonapalene has been researched along with arachidonic acid in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Black, AK; Camp, RD; Cunningham, FM; Greaves, MW; Hofbauer, M; Mallet, AI | 1 |
Calhoun, W; Carlson, RP; Chang, JY; Datko, L; Kreft, AF; Musser, JH; O'Neill-Davis, L | 1 |
Gibert, C; Moragas, JM; Puig, L; Solá, J; Vila, L | 1 |
Berks, AH; Jones, GH; Kruseman, M; Loe, BE; Maloney, PJ; Murthy, DV; Simpson, RA; Spires, DA; Venuti, MC; Young, JM | 1 |
Jones, GH; Loe, BE; Venuti, MC; Young, JM | 1 |
Fogh, K; Herlin, T; Iversen, L; Kragballe, K | 1 |
1 trial(s) available for lonapalene and arachidonic acid
Article | Year |
---|---|
Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adult; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Chromatography, High Pressure Liquid; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lipoxygenase Inhibitors; Male; Middle Aged; Naphthalenes; Psoriasis | 1990 |
5 other study(ies) available for lonapalene and arachidonic acid
Article | Year |
---|---|
Effect of a 5-lipoxygenase (5-LO)/cyclooxygenase (CO) inhibitor, WY-47, 288, on cutaneous models of inflammation.
Topics: Animals; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Cyclooxygenase Inhibitors; Disease Models, Animal; Ear; Erythema; Female; Guinea Pigs; Inflammation; Lipoxygenase Inhibitors; Mice; Naphthalenes; Quinolines; Radiation Injuries; Salicylates; Skin; Skin Diseases; Tetradecanoylphorbol Acetate; Ultraviolet Rays | 1989 |
Effect of lonapalene on metabolism of exogenous arachidonic acid in human platelets.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Chromatography, High Pressure Liquid; Eicosanoids; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Lipoxygenase; Naphthalenes; Prostaglandin-Endoperoxide Synthases | 1989 |
Topical nonsteroidal antipsoriatic agents. 1. 1,2,3,4-Tetraoxygenated naphthalene derivatives.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Topical; Animals; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Biological Assay; Edema; Female; Humans; Lipoxygenase Inhibitors; Mice; Naphthalenes; Neutrophils; Ornithine Decarboxylase Inhibitors; Oxygen; Psoriasis; Structure-Activity Relationship; Tetrahydronaphthalenes | 1986 |
Topical nonsteroidal antipsoriatic agents. 2. 2,3-(Alkylidenedioxy)naphthalene analogues of lonapalene.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arachidonic Acids; Edema; Mice; Naphthalenes; Psoriasis; Structure-Activity Relationship | 1988 |
Modulation of eicosanoid formation by lesional skin of psoriasis: an ex vivo skin model.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Arachidonic Acid; Calcimycin; Chromatography, High Pressure Liquid; Dinoprostone; Eicosanoids; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Leukotriene B4; Lipoxygenase Inhibitors; Naphthalenes; Psoriasis; Radioimmunoassay; Skin | 1993 |